EP2298279 - Bibliographic data

Compositions pharmaceutiques pour l'inhalation

Last update 19/07/2025
Legal status Brevet déchu
Origin Européen

(73) Holder

Vectura Limited

1 Prospect West
Chippenham, Wiltshire SN14 6FH
Royaume-Uni
(72) Inventors

John Nicholas Staniforth

The Byre Claverton
Bath BA2 7BG
Royaume-Uni

Haggis Harris

Vectural Limited 76 Shaftesbury Avenue Montpellier
Bristol, BS6 5LY
Royaume-Uni

David Alexander Vodden Morton

Vectura Limited 2nd Floor Flat Linsley House Beechen Cliff Road
Bath, Bath and North East Somerset BA2 4QR
Royaume-Uni

Robin Bannister

Vectura Limited 28 Summerhill Road
Saffron Walden, Essex CB11 4AJ
Royaume-Uni
(74) Agent

Mail recipient

Summersell, Richard John

Vectura Limited 205 Cambridge Science Park Milton Road
Cambridge CB4 0GZ
Royaume-Uni

(21) Request number EP10182218.7
(22) Request date 30/11/2001

(11) Publication number EP2298279
Publication date 14/11/2018

(54) Title of the invention Compositions pharmaceutiques pour l'inhalation
(51) International classification A61K 9/00A61K 47/28
International classification (before reform) None

Claimed priority

(31) Number: 0029261
(32) Date: 30/11/2000
(33) Country: GB

Initial application None
Divisional application None

Expected annuity Annuity: 18 - Amount: 355 € - Due date 14/01/2019
Surtax: 18 - Amount: 71 € - Due date 15/07/2019
Last annuity None

Publication None
History

Publication de la délivrance du brevet européen - Legal date 14/11/2018


Modification du mandataire OEB du brevet européen - Legal date 26/10/2018


Entrée en période de grâce du brevet d'invention - Legal date 15/01/2019


Déchéance du brevet d'invention après période de grâce - Legal date 14/01/2019


Révocation du brevet européen - Legal date 26/10/2023